ArticleJournal of experimental & clinical cancer research : CR2021

High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.

Elisabetta Falvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.